Search

Author/Creator Nagatani, Yoshiaki

2. Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer. Issue 4 (April 2022)

Authors:
Funakoshi, Yohei; Yakushijin, Kimikazu; Ohji, Goh; Hojo, Wataru; Sakai, Hironori; Takai, Ryo; Nose, Taku; Ohata, Shinya; Nagatani, Yoshiaki; Koyama, Taiji; Kitao, Akihito; Nishimura, Meiko; Imamura, Yoshinori; Kiyota, Naomi; Harada, Kenichi; Tanaka, Yugo; Mori, Yasuko; Minami, Hironobu
Journal:
Journal of infection and chemotherapy
Issue:
Volume 28:Issue 4(2022)
Page Start:
516
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria. Issue 6 (December 2018)

Authors:
Goto, Hideaki; Kiyota, Naomi; Otsuki, Naoki; Imamura, Yoshinori; Chayahara, Naoko; Suto, Hirotaka; Nagatani, Yoshiaki; Toyoda, Masanori; Mukohara, Toru; Nibu, Ken-ichi; Kasahara, Toshihiko; Ito, Yasuhiro; Miya, Akihiro; Hirokawa, Mitsuyoshi; Miyauchi, Akira; Minami, Hironobu
Journal:
Auris nasus larynx
Issue:
Volume 45:Issue 6(2018)
Page Start:
1249
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗